IDH1 and oligodendroglioma: A prospective study by the European Organization for Research and Treatment of Cancer (EORTC) determining the prognostic significance of IDH mutation in anaplastic oligodendroglioma patients found that IDH mutant oligodendrogliomas had a better OS.